These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14095279)

  • 21. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 22. AMINO METHYL CYCLOHEXANE CARBOXYLIC ACID (AMCHA), A NEW SYNTHETIC FIBRINOLYTIC INHIBITOR.
    DUBBER AH; MCNICOL GP; DOUGLAS AS
    Br J Haematol; 1965 Mar; 11():237-45. PubMed ID: 14262183
    [No Abstract]   [Full Text] [Related]  

  • 23. [ON THE NEUTRALIZING PROPERTIES OF HUMAN AND ANIMAL SERUMS AGAINST THE GELATINOLYTIC AND FIBRINOLYTIC POWER OF TRYPSIN AND ALPHA-CHYMOTRYPSIN].
    RICHOU R; THEVENOT R; QUINCHON C
    Rev Immunol Ther Antimicrob; 1963; 27():357-61. PubMed ID: 14111202
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 25. STABILITY OF PANCREATIC DEOXYRIBONUCLEASE IN THE PRESENCE OF PROTEASES.
    MAXWELL RE; NICKEL VS; LEWANDOWSKI V
    J Pharm Sci; 1963 Aug; 52():796-7. PubMed ID: 14060465
    [No Abstract]   [Full Text] [Related]  

  • 26. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS.
    VONKAULLA KN
    Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277
    [No Abstract]   [Full Text] [Related]  

  • 27. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 28. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
    MARKWARDT F; KLOECKING HP; RICHTER M
    Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957
    [No Abstract]   [Full Text] [Related]  

  • 29. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 30. An antiproteolytic and antifibrinolytic preparation obtained from the potato by means of chromatography on SE-sephadex C-50.
    Worowski K
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):617-32. PubMed ID: 4375312
    [No Abstract]   [Full Text] [Related]  

  • 31. [RELATION OF ANTIPLASMIN AND ANTITRYPSIN IN THE BLOOD PLASMA].
    MAKI M
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Oct; 15():1143-6. PubMed ID: 14092838
    [No Abstract]   [Full Text] [Related]  

  • 32. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():590-7. PubMed ID: 14098708
    [No Abstract]   [Full Text] [Related]  

  • 33. INHIBITION OF THE FIBRINOGEN-PLASMIN REACTION BY OMEGA-AMINOCARBOXYLIC ACIDS AND ALKYLAMINES.
    BICKFORD AF; TAYLOR FB; SHEENA R
    Biochim Biophys Acta; 1964 Nov; 92():328-33. PubMed ID: 14249121
    [No Abstract]   [Full Text] [Related]  

  • 34. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
    Veremienko KN; Varetskaia TV; Kizim AI; Gerasimenko NG
    Ukr Biokhim Zh; 1976; 48(3):337-42. PubMed ID: 134480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 38. EFFECT OF BENTONITE ON FIBRINOLYTIC SYSTEM IN SERUM.
    OLESEN ES
    Thromb Diath Haemorrh; 1963 Nov; 10():120-32. PubMed ID: 14081274
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteases and antiproteasic substances in the inflammatory response.
    Bertelli A
    Biochem Pharmacol; 1968 Mar; ():Suppl:229-40. PubMed ID: 4297370
    [No Abstract]   [Full Text] [Related]  

  • 40. Trinitrophenyl-derivative of urinary trypsin inhibitor: a strong antifibrinolytic agent.
    Sumi H; Hamada H; Maehara S; Yoshida E; Tsushima H; Maruyama M; Mihara H
    Acta Haematol; 1987; 78(4):225-8. PubMed ID: 2962413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.